Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M46,754Revenue $M20,314Net Margin (%)6.3Z-Score1.7
Enterprise Value $M57,712EPS $1.5Operating Margin %8.1F-Score7
P/E(ttm))33.7Cash Flow Per Share $5.9Pre-tax Margin (%)6.2Higher ROA y-yN
Price/Book2.010-y EBITDA Growth Rate %14.5Quick Ratio0.7Cash flow > EarningsY
Price/Sales2.35-y EBITDA Growth Rate %-1.3Current Ratio1.2Lower Leverage y-yN
Price/Cash Flow7.3y-y EBITDA Growth Rate %20.0ROA % (ttm)2.7Higher Current Ratio y-yY
Dividend Yield %2.1Insider Buy (3m)0ROE % (ttm)5.6Less Shares Outstanding y-yY
Payout Ratio %69.0Shares Outstanding M851ROI % (ttm)0.2Gross Margin Increase y-yY

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TEVAGeorge Soros 2014-03-31 Add0.52%$39.88 - $50.22
($45.91)
$ 54.9520%Add 10.67%10,310,041
TEVADavid Dreman 2014-03-31 Add0.15%$39.88 - $50.22
($45.91)
$ 54.9520%Add 24.43%183,323
TEVAJohn Keeley 2014-03-31 Buy 0.04%$39.88 - $50.22
($45.91)
$ 54.9520%New holding, 47435 sh.47,435
TEVAGeorge Soros 2013-12-31 Add1.96%$36.59 - $41.7
($39.39)
$ 54.9540%Add 158.2%9,316,000
TEVAJames Barrow 2013-12-31 Add0.31%$36.59 - $41.7
($39.39)
$ 54.9540%Add 79.64%12,143,563
TEVAMichael Price 2013-12-31 Add0.26%$36.59 - $41.7
($39.39)
$ 54.9540%Add 14.29%400,000
TEVAGeorge Soros 2013-09-30 Buy 1.5%$37.43 - $41.27
($39.03)
$ 54.9541%New holding, 3608000 sh.3,608,000
TEVAVanguard Health Care Fund 2013-09-30 Add0.23%$37.43 - $41.27
($39.03)
$ 54.9541%Add 15.71%13,145,600
TEVADavid Abrams 2013-09-30 Sold Out -5.8%$37.43 - $41.27
($39.03)
$ 54.9541%Sold Out0
TEVARonald Muhlenkamp 2013-06-30 Reduce-0.99%$37.8 - $40.23
($38.94)
$ 54.9541%Reduce -41.05%169,660
TEVAGeorge Soros 2013-06-30 Sold Out -0.02%$37.8 - $40.23
($38.94)
$ 54.9541%Sold Out0
TEVAVanguard Health Care Fund 2013-03-31 Add0.21%$37.19 - $41.06
($38.57)
$ 54.9542%Add 13.37%11,361,300
TEVAJames Barrow 2013-03-31 Add0.2%$37.19 - $41.06
($38.57)
$ 54.9542%Add 64.42%7,078,456
TEVAJohn Burbank 2013-03-31 Sold Out -0.11%$37.19 - $41.06
($38.57)
$ 54.9542%Sold Out0
TEVAGeorge Soros 2013-03-31 Reduce-0.04%$37.19 - $41.06
($38.57)
$ 54.9542%Reduce -66.67%50,000
TEVAMichael Price 2012-12-31 Add1.36%$36.95 - $42.52
($39.94)
$ 54.9538%Add 250%350,000
TEVAJames Barrow 2012-12-31 Add0.13%$36.95 - $42.52
($39.94)
$ 54.9538%Add 68.67%4,305,129
TEVAJohn Burbank 2012-12-31 Buy 0.11%$36.95 - $42.52
($39.94)
$ 54.9538%New holding, 75000 sh.75,000
TEVAScott Black 2012-12-31 Sold Out -0.21%$36.95 - $42.52
($39.94)
$ 54.9538%Sold Out0
TEVAGeorge Soros 2012-12-31 Reduce-0.08%$36.95 - $42.52
($39.94)
$ 54.9538%Reduce -45.45%150,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TEVA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
TEVA John Keeley 2014-03-3147,4350.010.04New Buy
TEVA David Dreman 2014-03-31183,3230.020.75+24.43%
TEVA George Soros 2014-03-3110,310,0411.215.4+10.67%
TEVA James Barrow 2014-03-3113,335,7671.571+9.82%
TEVA Jean-Marie Eveillard 2014-03-3120000
TEVA Ronald Muhlenkamp 2014-03-31175,4400.021.6-0.51%
TEVA Tom Gayner 2014-03-31694,0000.081.1-0.84%
TEVA Michael Price 2014-03-31388,4000.052.5-2.9%
TEVA Vanguard Health Care Fund 2014-03-3112,350,9001.451.8-6.05%
Premium Most recent portfolio changes are included for Premium Members only!


TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about TEVA :

Quarterly/Annual Reports about TEVA:

    News about TEVA:

    Articles On GuruFocus.com
    George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps Selling GOOGL, BA, MSFT, HAR Jul 16 2014 
    Diamond Hill Capital Comments on Teva Pharmaceutical Industries Ltd Jun 26 2014 
    Diamond Hill Select Fund Commentary – First Quarter 2014 Jun 25 2014 
    Top Guru Held Asian Companies of the First Quarter Jun 03 2014 
    George Soros Reports Top Five Stocks May 23 2014 
    Richard Snow's Top Five Highlight Finance and Healthcare Sectors May 14 2014 
    Wrong Marketing Lesson by Big Pharma May 03 2014 
    Should You Buy Actavis? Mar 18 2014 
    Forest Laboratories' Recovery Mar 18 2014 
    Top Five Guru-Held Asian Stocks at Year End Mar 05 2014 


    More From Other Websites
    How Teva Pharmaceutical Is Attacking the Generics to Defend Its Turf Jul 23 2014
    Israel's Market Appears Unfazed By Rising Conflict Jul 22 2014
    Teva Completes Acquisition of Labrys: Opens Door to a Strong and Novel Migraine Prevention and... Jul 21 2014
    UBS Lists 6 Stocks With Positive Catalysts Coming Soon Jul 18 2014
    Teva to Report Second Quarter 2014 Financial Results on July 31, 2014 Jul 18 2014
    Leading U.S. Proxy Advisory Firm Supports Teva Nominees and Other Shareholders’ Meeting Proposals Jul 16 2014
    Leading U.S. Proxy Advisory Firm Supports Teva Nominees and Other Shareholders’ Meeting Proposals Jul 16 2014
    Teva faces fresh shareholder showdown over management structure Jul 14 2014
    Teva Says No Chairman Chosen After Investor Names Elstein Jul 14 2014
    Israeli industrialist Landa leads investor bid to shake up Teva Pharm board Jul 14 2014
    Teva to name new chairman - activist investor Landa says Jul 14 2014
    Teva to name new chairman - activist investor Landa says Jul 14 2014
    Teva Announces FDA Acceptance of NDA Filing for Investigational Short-Acting Beta-Agonist (SABA)... Jul 14 2014
    Will Teva Pharmaceuticals (TEVA) Stock Be Affected By EU Fine? Jul 09 2014
    Teva's Contraceptive Gets Positive CHMP Opinion Jul 07 2014
    Making The Case For Teva Jul 07 2014
    Teva Receives CHMP Positive Opinion for Seasonique® Extended-Regimen Contraceptive for Marketing... Jul 04 2014
    Teva files petition with U.S. FDA against MS drug competitors Jul 03 2014
    ADDING MULTIMEDIA Teva Files Citizen Petition with the U.S. Food and Drug Administration (FDA)... Jul 03 2014
    Teva files petition with FDA regarding COPAXONE Jul 03 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide